
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

21,934 Listeners

43,890 Listeners

31,993 Listeners

38,498 Listeners

6,789 Listeners

43,618 Listeners

27,151 Listeners

2,875 Listeners

9,192 Listeners

464 Listeners

723 Listeners

945 Listeners

6,408 Listeners

922 Listeners

99 Listeners